Reviews in Endocrine and Metabolic Disorders
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 8.7 | Q1 | 93.5% | 2.834 | Q1 | 97.4% |
| 2024 | 8.0 | Q1 | 92.7% | 2.446 | Q1 | 96.7% |
| 2023 | 6.9 | Q1 | 90.0% | 2.075 | Q1 | 95.8% |
| 2022 | 8.2 | Q1 | 91.3% | 1.835 | Q1 | 95.0% |
| 2021 | 9.3 | Q1 | 91.0% | 1.780 | Q1 | 95.0% |
| 2020 | — | — | 1.916 | Q1 | 95.2% | |
| 2019 | — | — | 1.641 | Q1 | 93.7% | |
| 2018 | — | — | 1.929 | Q1 | 94.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1389-9155
ISSN
1573-2606
country
UScoverage
2000-2026